Search Results

You searched for : Moleculin

	Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas The FDA grants orphan drug designation to drugs and biologics that are intended for the treatment of rare diseases that affect fewer than 200,000 ... Dec 30
	Moleculin announces Annamycin receives USFDA orphan drug designation for soft tissue sarcomas Annamycin is capable of reaching 6 to 34-fold higher levels of accumulation in the lungs than that of doxorubicin, the primary first-line chemotherapy ... Dec 29
	Moleculin announces FDA approval of 3 Rare pediatric disease designations for WP1066 The designation entitles Moleculin to receive a transferrable Priority Review Voucher (PRV) upon New Drug Approval (NDA)... Dec 03
	Moleculin announces new antiviral drug candidates to treat HIV Moleculin declares new antiviral drug candidates demonstrate in vitro activity against HIV. Also shows activity in Zika and Dengue Fever ... Oct 06
	Moleculin Biotech discovered a molecule, displayed significant in vitro antiviral activity against SARS-CoV-2 The pharma co. anticipates it will take at least twelve months of development work to assess clinical potential for these new molecules... Sep 29
	Sterling signs deal to produce potential COVID-19 Drug for Moleculin Sterling Signs Deal to contract manufacture COVID-19 Drug Candidate for Moleculin ... Jul 28
6 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas

Moleculin announces Annamycin receives USFDA orphan drug designation for soft tissue sarcomas

Moleculin announces FDA approval of 3 Rare pediatric disease designations for WP1066

Moleculin announces new antiviral drug candidates to treat HIV

Moleculin Biotech discovered a molecule, displayed significant in vitro antiviral activity against SARS-CoV-2

Sterling signs deal to produce potential COVID-19 Drug for Moleculin

Trending Now